Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 937-947

  Cescon, Matteo ^a   Carini, Rita ^b   Grazi, Gianluca ^a   Caraceni, Paolo ^a   Alchera, Elisa ^b   Gasloli, Giorgio ^b   Ravaioli, Matteo ^a   Tuci, Francesco ^a   Imarisio, Chiara ^b   Ponte, Caterina Dal ^b   Pertosa, Anna Maria ^a   Bernardi, Mauro ^a   Pinna, Antonio D ^a   Albano, Emanuele ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Hepatoprotection; Ischemia reperfusion; Liver transplantation; PKB Akt; PTEN

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTHROMBIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CADAVER DONOR; CALCULATION; CHROMOSOME 10; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; ISCHEMIC PRECONDITIONING; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; RODENT; STATISTICAL SIGNIFICANCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

EID: 64549134597     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.11.016     Document Type: Article

References (40)

1. Serracino-Ingold F., Habib N.A., and Mathie R.T. Hepatic ischemia-reperfusion injury. Am J Surg 181 (2001) 160-166
2. Selzner M., and Clavien P.A. Fatty liver in liver transplantation and surgery. Semin Liver Dis 21 (2001) 105-113
3. Varotti G., Grazi G.L., Vetrone G., Ercolani G., Cescon M., Del Gaudio M., et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 19 (2005) 492-500
4. Rull R., Vidal O., Momblan D., González F.X., López-Boado M.A., Fuster J., et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl 9 (2003) 389-393
5. Selzner N., Rudiger H., Graf R., and Clavien P.A. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917-936
6. Banga R.N., Homer-Vanniasikam S., Graham A., Al-Mukhtar A., White S.A., and Prasad K.R. Ischemic preconditioning in transplantation and major resection of the liver. Br J Surg 92 (2005) 528-538
7. Clavien P.A., Selzner M., Rudiger H.A., Graf R., Kadry Z., Rousson V., et al. Prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238 (2003) 843-852
8. Petrowsky H., McCormack L., Trujillo M., Selzner M., Jochum W., and Clavien P.A. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 244 (2006) 921-930
9. Carrasco-Chaumel E., Roselló-Catafau J., Bartrons R., Franco-Gou R., Xaus C., Casillas A., et al. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 43 (2005) 997-1006
10. Franco-Gou R., Roselló-Catafau J., Casillas-Ramirez A., Massip-Salcedo M., Rimola A., Calvo N., et al. How ischemic preconditioning protects small liver grafts. J Pathol 208 (2006) 62-73
11. Koneru B., Fisher A., He Y., Klein K.M., Skurnick J., Wilson D.J., et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 11 (2005) 196-202
12. Azoulay D., Del Gaudio M., Andreani P., Ichai P., Sebag M., Adam R., et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 242 (2005) 133-139
13. Cescon M., Grazi G.L., Grassi A., Ravaioli M., Vetrone G., Ercolani G., et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 12 (2006) 628-635
14. Jassem W., Fuggle S.V., Cerundolo L., Heaton N.D., and Rela M. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 81 (2006) 169-174
15. Amador A., Grande L., Marti{dotless}́ J., Deulofeu R., Miquel R., Solá A., et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 7 (2007) 2180-2189
16. Koneru B., Shareef A., Dikdan G., Desai K., Klein K.M., Peng B., et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant 7 (2007) 2788-2796
17. Carini R., and Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 (2003) 1480-1491
18. Izuishi K., Tsung A., Hossain M.A., Fujiwara M., Wakabayashi H., Masaki T., et al. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 44 (2006) 573-580
19. Carini R., De Cesaris M.G., Splendore R., Baldanzi G., Nitti M.P., Alchera E., et al. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 127 (2004) 914-923
20. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
21. Webster C.R., and Anwer M.S. Phosphoinositide-3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 33 (2001) 608-615
22. Hatano E., and Brenner D.A. Akt protects mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis through NF-kB activation. Am J Physiol 282 (2002) G1357-G1368
23. Muller C., Dunshede F., Koch E., Vollmar A.M., and Kiemer A.K. Alpha-lipoic preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol 285 (2003) G769-G778
24. Starzl T.E., Hakala T.R., Shaw Jr. B.W., Hardesty R.L., Rosenthal T.J., Griffith B.P., et al. A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet 158 (1984) 223-230
25. Peterson G.L. A simplification of the protein assay method of Lowry, which is more generally applicable. Anal Biochem 83 (1977) 346-356
26. Zamboni F., Franchello A., David E., Rocca G., Ricchiuti A., Lavezzo B., et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15 (2001) 53-57
27. Tanguney T., and Stokoe D. New insights into PTEN. J Cell Sci 120 (2007) 4071-4079
28. De Oliveira M.L., Graf R., and Clavien P.A. Ischemic preconditioning: promises from the laboratory to patients. Sustained or disillusioned?. Am J Transplant 7 (2007) 1-3
29. Gurusamy K.S., Kumar Y., Sharma D., and Davidson B.R. Ischaemic preconditioning for liver transplantation. Cochrane Database Syst Rev 1 (2008) CD006315
30. Desai K.K., Dikdan G.S., Shareef A., and Koneru B. Ischemic preconditioning of the liver: a few perspectives from the bench to bedside translation. Liver Transpl 14 (2008) 1569-1577
31. Zhao H., Sapolsky R.M., and Steinberg G.K. Phosphoinositide-3-kinase/Akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34 (2006) 249-270
32. Hasenloy D.J., Tsang A., Mocanu M.M., and Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288 (2006) H971-H976
33. Gericke A., Munson M., and Ross A.H. Regulation of the PTEN phosphatase. Gene 374 (2006) 1-9
34. Cai Z., and Semenza G. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 97 (2005) 1351-1359
35. Omori N., Jin G., Li F., Zhang W.R., Wang S.J., Hamakawa Y., et al. Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral occlusion. Brain Res 954 (2002) 317-322
36. Lee J.H., Kim K.Y., Lee Y.K., Park S.Y., Kim C.D., Lee W.S., et al. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase tensin homologues deleted from chromosome 10 phosphorylation in rats. J Pharm Exp Ther 308 (2004) 896-903
37. Wu D.N., Pei D.S., Wang Q., and Zhang G.Y. Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3K/Akt during cerebral ischemia in rat hippocampus. Neurosci Lett 287 (2006) 28258-28263
38. Vinciguerra M., Veyrat-Durebex C., Moukil M.A., Rubbia-Brant L., Rohener-Jeanrenaud F., and Foti M. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via NF-kBp65/mTOR-dependent mechanisms. Gastroenterology 134 (2008) 268-280
39. De Ponti C., Carini R., Alchera E., Nitti M.P., Locati M., Albano E., et al. Adenosine A2A receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. J Leukoc Biol 82 (2007) 392-402
40. Alchera E., Tacchini L., Imarisio C., Dal Ponte C., De Ponti C., Gammella E., et al. Adenosine-dependent activation of hypoxia inducible factor 1 (HIF-1) induces late preconditioning in liver cells. Hepatology 48 (2008) 230-239